Lead Product(s) : Ibuprofen Lysinate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.
Details : Ibuprofen Lysine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 13, 2018
Lead Product(s) : Ibuprofen Lysinate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ibuprofen Lysinate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Simbec Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Ibuprofen and Paracetamol Pharmacokinetic Study
Details : Ibuprofen Lysine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 22, 2015
Lead Product(s) : Ibuprofen Lysinate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Simbec Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
